Evidence map›Paper›PMID 35292774›Full record

ArticleOncogene2022

Spatial collagen stiffening promotes collective breast cancer cell invasion by reinforcing extracellular matrix alignment.

Thijs Koorman, Karin A Jansen, Antoine Khalil, Peter D Haughton, Daan Visser, Max A K Rätze, Wisse E Haakma, Gabrielè Sakalauskaitè, Paul J van Diest, Johan de Rooij and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Oncogene, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 138 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Collagen remodeling in breast cancer progression: from molecular mechanisms to diagnostic and therapeutic opportunities.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Thijs KoormanDepartments of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-6064-3353
Karin A Jansen *Departments of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Antoine Khalil *Molecular Cancer Research/Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-3469-0778
Peter D Haughton *Departments of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Daan VisserDepartments of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-1062-8745
Max A K RätzeDepartments of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Wisse E HaakmaDepartments of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Gabrielè SakalauskaitèDepartments of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Paul J van DiestDepartments of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Johan de RooijMolecular Cancer Research/Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. J.deRooij-3@umcutrecht.nl.ORCID http://orcid.org/0000-0001-6101-7875
Patrick W B DerksenDepartments of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. p.w.b.derksen@umcutrecht.nl.ORCID http://orcid.org/0000-0003-0732-7762
University Medical Center Utrecht · NLUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tumor micro-environment often contains stiff and irregular-bundled collagen fibers that are used by tumor cells to disseminate. It is still unclear how and to what extent, extracellular matrix (ECM) stiffness versus ECM bundle size and alignment dictate cancer cell invasion. Here, we have uncoupled Collagen-I bundling from stiffness by introducing inter-collagen crosslinks, combined with temperature induced aggregation of collagen bundling. Using organotypic models from mouse invasive ductal and invasive lobular breast cancers, we show that increased collagen bundling in 3D induces a generic increase in breast cancer invasion that is independent of migration mode. However, systemic collagen stiffening using advanced glycation end product (AGE) crosslinking prevents collective invasion, while leaving single cell invasion unaffected. Collective invasion into collagen matrices by ductal breast cancer cells depends on Lysyl oxidase-like 3 (Loxl3), a factor produced by tumor cells that reinforces local collagen stiffness. Finally, we present clinical evidence that collectively invading cancer cells at the invasive front of ductal breast carcinoma upregulate LOXL3. By uncoupling the mechanical, chemical, and structural cues that control invasion of breast cancer in three dimensions, our data reveal that spatial control over stiffness and bundling underlie collective dissemination of ductal-type breast cancers.

Indexed as

Breast NeoplasmsCarcinoma, Ductal, BreastAnimalsCell Line, TumorCell MovementCollagenExtracellular MatrixFemaleHumansMiceNeoplasm InvasivenessTumor MicroenvironmentCollagen

Identifiers

PMID35292774
PMCPMC9033577
OpenAlexW4221048469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.